Drug discovery and development are expensive and time-consuming processes. Removing non-drug-like compounds from the drug discovery lifecycle in the early stages can lead to tremendous savings of resources. Structure information is increasingly used in the drug design process and has contributed significantly to the discovery of several marketed drugs and it is well known that in silico approaches are comparatively cheaper than in vivo and in vitro screenings. Since there is currently no research related to the structure based drugability studies of the compounds from spices (particularly by...